Tuesday, December 23, 2014 2:40 AM EST


GlaxoSmithKline is the world's fourth largest pharmaceutical company that was formed by the merger of GlaxoWellcome plc and SmithKline Beecham plc.  

It is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.

Headlines Around the Web

Glaxo to stop paying docs to promote drugs

Dec 18, 2013 - The Times of India

GSK to scrap individual sales targets

Dec 18, 2013 - New Zealand Herald

Stocks of MNCs see feel-good rally

Dec 17, 2013 - The Times of India

GSK lines up Rs 6,400cr open offer

Dec 17, 2013 - The Times of India

GSK to increase stake in its Indian pharma entity

Dec 16, 2013 - The Times of India

GSK to spend $1 billion to raise stake in Indian unit

Dec 16, 2013 - The Times of India

Takeda picks GSK executive as next CEO

Dec 01, 2013 - Financial Times

GSK sells chunk of shares in Aspen

Nov 20, 2013 - France24

Buffett takes $3.7bn stake in ExxonMobil

Nov 15, 2013 - Financial Times

Profits slide as AstraZeneca hires CFO

Oct 31, 2013 - Financial Times

China scandal takes toll on Glaxo

Oct 24, 2013 - CNN Money

Articles About GlaxoSmithKline

Scientists at the National Microbiology Lab in Winnipeg, Manitoba, prepare an experimental Ebola vaccine for shipment to the World Health Organization (WHO) in Geneva in this undated handout picture released October 18, 2014.
Ebola Vaccine Shows High Immune System Response In Early Tests; Australia Lifts Travel Ban on Congo

By IBTimes AU

The findings of the early human trial for Ebola vaccine proved to be promising and appeared to be safe on patients. (Nov 27)


An advertisement for donations to fight Ebola in Africa is displayed on a bus stop near the apartment building
Ebola Vaccine: Johnson & Johnson Confident Of Human Trials In January And Market Delivery in May Next Year

By IBTimes AU

It must be good news for the medical fraternity, which is now groping in the dark not knowing how to treat the drug-defying epidemic. (Oct 24)


Participants arrive at the opening of a consultation of international experts on potential Ebola therapies and vaccines in Geneva September 4, 2014. On September 4 and 5, the World Health Organization (WHO) will bring together 200 key experts to discuss e
WHO Races to Release Ebola Serum in 2 Weeks, Vaccines in January

By IBTimes AU

The WHO targets to release an Ebola blood serum within two weeks. (Oct 23)


Beware of Ebola-Killer Disease
Ebola Cure News Update: Melbourne Company To Join Global Research For Treatment

By IBTimes AU

A Melbourne company joins international effort for Ebola treatment research (Oct 16)


An Ebola Virus Treatment Center In Monrovia
No Ebola Vaccine Until Mid-2015: Reasons Why It Is Difficult To Create A Cure Or Vaccine

By IBTimes AU

Vaccines are made to protect humans and animals from severe or life-threatening diseases. (Oct 03)


Health Workers Prepare To Carry An Abandoned Dead Body Presenting With Ebola Symptoms At Duwala Market In Monrovia
Hoax Alert: 'Ebola Vaccine Only Works on White Skin' Viral Story Not True

By IBTimes AU

A viral story about an Ebola vaccine working only people with white skin is a hoax and should be believed to be true. The source of the story has claimed it is a satire website and everything it publishes is meant for "entertainment purposes. (Sep 29)

A man washes his hands as a preventive measure against the Ebola virus on a street in Monrovia, September 13, 2014. REUTERS/James Giahyue (LIBERIA - Tags: HEALTH SOCIETY)
UK Starts Ebola Vaccine Trials on Humans

By IBTimes AU

A former NHS nurse has become the first volunteer from the U.K. to undertake the Ebola vaccine trial on humans. (Sep 18)


Workers from Doctors Without Borders unload emergency medical supplies to deal with Ebola
CDC Fears Ebola Virus 'Out of Control'; Human Trials On Third Vaccine To Begin Early 2015

By IBTimes AU

Ebola is feared to be "spiraling out of control" as disease experts and healthcare workers scramble to keep the virus contained. A third vaccine is scheduled to be tested on humans early next year. (Sep 05)

Workers from Doctors Without Borders unload emergency medical supplies to deal with Ebola
Ebola Drug: Human Trial Begins In America

By IBTimes AU

A legally valid Ebola vaccine will be a great relief to those suffering from the disease and can save many lives (Sep 04)


Health Workers Carry The Body Of An Ebola Virus Victim In Kenema, Sierra Leone
Ebola Outbreak: Vaccine Trials on Humans to Begin Soon, Could Be Marketed By 2015

By IBTimes AU

Clinical tests for possible Ebola vaccine to start in September 2014. (Aug 11)